	Validation of the cognitive fusion questionnaire in regular meditators and persons with schizophrenia spectrum disorders. Front Psychol Bergmann N, Conell I, Hahne I, Zierhut M, Ta TMT, Hahn E, Böge K. PMID: 42005019 [PubMed]
	Jumping to conclusions and social behavior in individuals diagnosed with schizophrenia. Schizophr Res Cogn Hayashi R, Takahama Y, Inadomi H, Ishii R, Watanabe S, Yoshida K, Okada H, Yoshimura M. PMID: 42004482 [PubMed - as supplied by publisher]
	Developmental trajectories of social responsiveness and theory of mind in adolescent offspring at familial high-risk of schizophrenia or bipolar disorder and population-based controls-The Danish High Risk and Resilience Study, VIA 15. Br J Clin Psychol Veddum L, Laursen AF, Bundgaard AF, Hemager N, Gregersen M, Krantz MF, Vaskinn A, Jepsen JRM, Søndergaard A, Rohd SB, Wilms M, Schiavon M, Streymá DHB, Thorup AAE, Nordentoft M, Mors O, Greve AN. PMID: 42003073 [PubMed - as supplied by publisher]
	Metabolic syndrome in chronic schizophrenia: Cross-sectional hospital assessment of prolonged risperidone exposure. Pak J Pharm Sci Wu Y, Wu J, Deng Z, Xiao T. PMID: 42001294 [PubMed - indexed for MEDLINE]
	Task-based fNIRS biomarkers of HD-tDCS treatment for negative symptoms in schizophrenia. Schizophr Res Lin CE, Chen LF, Sack AT, Chang HA. PMID: 42000633 [PubMed - as supplied by publisher]
	Cannabis and Tobacco Co-Use is Associated with Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis. Biol Psychiatry Cogn Neurosci Neuroimaging Bello D, Connolly JG, Addington J, Bearden CE, Cadenhead K, Cannon TD, Cornblatt B, Keshavan M, Mathalon DH, Perkins DO, Seidman L, Stone WS, Tsuang MT, Walker EF, Woods S, Brady RO Jr, Carrión RE, Ward HB. PMID: 41999882 [PubMed - as supplied by publisher]
	What are the experiences of people with psychosis, their carers and staff in inpatient mental healthcare services in the United Kingdom? A systematic review and meta-ethnography. Br J Clin Psychol MacDonald-Winship LA, Schröder TA, Lane S. PMID: 41999092 [PubMed - as supplied by publisher]
	Cognitive behavioral therapy for insomnia vs. standard cognitive behavioral therapy for sleep and circadian disturbances in treatment-resistant schizophrenia: study protocol for the randomized controlled trial (COSTS). Trials Johansen JF, Nielsen MØ, Kragh M, Nielsen J. PMID: 41998739 [PubMed - indexed for MEDLINE]
	Finding risk factors for dementia in patients with schizophrenia: a population-based case-control study. BMC Psychiatry Ho CP, Hsu KL, Chang WC, Hsieh TC. PMID: 41998529 [PubMed - as supplied by publisher]
	Schizophrenia and frontotemporal dementia: distinct diseases with converging circuit dysfunctions. Neuroscience Casile A, Sapienza J, Vasciaveo V, Barzon B, Nasini S, Guarato G, Ave C, Martini F, Bosia M, Comai S. PMID: 41997556 [PubMed - as supplied by publisher]
	Perinatal stress as a moderator of the effects of hormonal dysregulation on cognition and symptoms in early psychosis. Schizophr Res Gago E, Montalvo I, Cabezas Á, Ortega L, Solé M, Martorell L, Vilella E, García-Rizo C, Labad J. PMID: 41996952 [PubMed - as supplied by publisher]
	Common molecular signatures: the role of BDNF, melatonin, and orexin in the ASD-schizophrenia continuum. Mol Biol Rep Alruwaili NS, Al-Kuraishy HM, Al-Gareeb AI, Shokr MM, Bogari NM, Alhelfawi S, Alruwaili M, El-Saber Batiha G. PMID: 41995757 [PubMed - in process]
	Subtle impairments of facial emotion expressions in individuals at ultra-high risk for psychosis. Front Psychiatry Kristensen TD, Ebdrup BH, Ambrosen KS, Nordentoft M, Glenthøj LB, Grasshof S. PMID: 41993838 [PubMed]
	Dose effect of buspirone combined with clozapine on cognitive function in patients with schizophrenia. Br J Clin Pharmacol Xia Y, Song C, Zhang J, Zhu W, Xu H. PMID: 41992539 [PubMed - as supplied by publisher]
	Long-term regular follow-up yields important benefits in forensic psychiatric patients with psychosis: A 2-year longitudinal study on psychopathology, general health, quality of life, and functioning. J Forensic Sci Bali P, Markopoulou M, Douzenis P, Tasios K, Rizos E, Michopoulos I, Douzenis A. PMID: 41992431 [PubMed - as supplied by publisher]
	Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia. Am J Psychiatry Ku SH, Stringfield SJ, Torregrossa MM, Sweet RA, Chou S. PMID: 41992094 [PubMed - as supplied by publisher]
	Neural underpinnings of verbal memory encoding and recognition impairments in individuals with clinically stable mood or schizophrenia spectrum disorders. Psychiatry Res Neuroimaging Segerlin SV, Damgaard V, Jespersen AE, Schandorff JM, Thommesen KK, Sankar A, Fisher PM, Macoveanu J, Miskowiak KW. PMID: 41990724 [PubMed - as supplied by publisher]
	Are routinely collected clinical and sociodemographic characteristics associated with social functioning and activities of daily living in schizophrenia? A machine learning approach descriptive of a schizophrenia cohort. PLoS One Barbalat G, Plasse J, Chéreau-Boudet I, Gouache B, Guillard-Bouhet N, Legros-Lafarge E, Franck N. PMID: 41990013 [PubMed - indexed for MEDLINE]
	Anton Boisen Resurrected: Prophetic Vision and the Hermeneutical Treatment of Psychosis. J Relig Health McCullough GJ. PMID: 41989651 [PubMed - as supplied by publisher]
	Peripheral lncRNA-IL1RAP Dysregulation in Schizophrenia: A Multi-Omics Bridge Between Immunity and Diagnosis. Brain Behav Wu J, Niu R, Liu Z, Li Y, Zhang Y, Teng Z, Zeng Y, Bao T. PMID: 41988836 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 68588

Page 1 of 3430



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy